Chinese heart valve device maker Venus Medtech nabs $308m in HK IPO

Chinese heart valve device maker Venus Medtech nabs $308m in HK IPO

Hong Kong

Venus Medtech, a Chinese company that produces heart valve replacement devices, has raised HK$2.41 billion ($308 million) in an initial public offering (IPO) on the Hong Kong stock exchange on Tuesday, becoming the latest healthcare company to shore up investors’ confidence in the Asian financial hub.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter